Virax Biolabs Group (NASDAQ:VRAX – Get Free Report) and Assure (OTCMKTS:IONM – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership and valuation.
Profitability
This table compares Virax Biolabs Group and Assure’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Virax Biolabs Group | N/A | N/A | N/A |
| Assure | N/A | N/A | N/A |
Analyst Ratings
This is a summary of recent recommendations for Virax Biolabs Group and Assure, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Virax Biolabs Group | 1 | 1 | 1 | 0 | 2.00 |
| Assure | 0 | 0 | 0 | 0 | 0.00 |
Risk & Volatility
Virax Biolabs Group has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500. Comparatively, Assure has a beta of 198.38, suggesting that its share price is 19,738% more volatile than the S&P 500.
Insider & Institutional Ownership
8.6% of Virax Biolabs Group shares are held by institutional investors. Comparatively, 3.3% of Assure shares are held by institutional investors. 45.1% of Virax Biolabs Group shares are held by insiders. Comparatively, 3.8% of Assure shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Valuation & Earnings
This table compares Virax Biolabs Group and Assure”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Virax Biolabs Group | $10,000.00 | 229.60 | -$5.02 million | N/A | N/A |
| Assure | $149,000.00 | 0.01 | -$26.08 million | ($56.12) | -0.00 |
Virax Biolabs Group has higher earnings, but lower revenue than Assure.
Summary
Virax Biolabs Group beats Assure on 7 of the 9 factors compared between the two stocks.
About Virax Biolabs Group
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name. It also develops T-Cell IVD test kit for COVID-19, which intend to adapt for immunological profiling against multiple viral threats under the ViraxImmune Brand, as well as a proprietary mobile application for ViraxImmune that presents an individual's immunological profiling data and provide advice on the users' immune system. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, pharmaceutical companies, research institutions, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.
About Assure
Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.
Receive News & Ratings for Virax Biolabs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virax Biolabs Group and related companies with MarketBeat.com's FREE daily email newsletter.
